Hyperbaric Oxygen TherapyrctRCT2001

Angiogenesis in necrotic ulcers treated with hyperbaric oxygen.

Ostomy/wound management

confidence

Key findings

THOT healed 90% of necrotic wounds vs 22% SWC, with smaller ulcers and significantly higher capillary density indicating enhanced angiogenesis.

View source on PubMed (PMID 11189538) ↗

Sample size
40 inpatients (79 ulcers)
Population
Inpatients with necrotic/gangrenous wounds
Dosing
Topical hyperbaric oxygen at 1.004 to 1.013 atmospheres
Duration
4 weeks (recruited over 12 months)
Route
Topical hyperbaric oxygen (THOT)
Blinding
not_reported
Controls
active_comparator
Drug class
physical modality

Measured endpoints

  • wound healing rateImprovedwound_healing
    significanteffect: 90% healed (THOT) vs 22% (SWC)
  • ulcer size at 4 weeksDecreasedwound_healing
    significanteffect: F(1,55) = 68.2
  • capillary density (angiogenesis)Increasedcardiovascular
    significant
Full abstract

Necrotic/gangrenous wounds lack adequate blood supply and develop further vascular damage from either reperfusion injury or oxygen toxicity when exposed to oxygen at the wrong pressures. A prospective randomized study was performed to confirm the efficacy of topical hyperbaric oxygen at 1.004 to 1.013 atmospheres (THOT) in stimulating angiogenesis and healing of necrotic/gangrenous wounds. Participants included 40 inpatients (79 ulcers) recruited over 12 months who were assigned to treatment by either THOT or standard wound care (SWC). The results showed that 90% of the wounds healed in the THOT group compared to 22% in the SWC controls. Repeated measures ANOVA on log (ulcer size at 4 weeks) showed a significant group by time interaction, F(1,55) = 68.2, P < 0.0001. The size of ulcers (at 4 weeks) was significantly smaller with THOT, but larger with SWC. Capillary density/hpf (high power field) was significantly higher in THOT wounds than in SWC wounds (P < 0.001). It was concluded that THOT is effective in stimulating angiogenesis with enhanced healing of necrotic wounds.

Research information, not medical advice. StudyKit summarizes published studies to help you understand your protocol. It does not diagnose, treat, or replace a clinician. Talk to a qualified provider before changing anything you take.